• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者肝脏再生结节的组织发生。

The histogenesis of regenerative nodules in human liver cirrhosis.

机构信息

Centre for Diabetes, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

出版信息

Hepatology. 2010 Mar;51(3):1017-26. doi: 10.1002/hep.23483.

DOI:10.1002/hep.23483
PMID:20198634
Abstract

UNLABELLED

Here, we investigate the clonality and cells of origin of regenerative nodules in human liver cirrhosis using mitochondrial DNA (mtDNA) mutations as markers of clonal expansion. Mutated cells are identified phenotypically by deficiency in the entirely mtDNA encoded cytochrome c oxidase (CCO) enzyme by histochemical and immunohistochemical methods. Nodules were classified as either CCO-deficient or CCO-positive, and among 526 nodules from 10 cases, 18% were homogeneously CCO-deficient, whereas only 3% had a mixed phenotype. From frozen sections, hepatocytes were laser-capture microdissected from several sites within individual CCO-deficient nodules. Mutations were identified by polymerase chain reaction sequencing of the entire mtDNA genome. In all cases except for one, the nodules were monoclonal in nature, possessing up to four common mutations in all hepatocytes in a given nodule. Moreover, the identification of identical mutations in hepatic progenitor cells abutting CCO-deficient nodules proves that nodules can have their origins from such cells.

CONCLUSION

These data support a novel pathway for the monoclonal derivation of human cirrhotic regenerative nodules from hepatic progenitor cells.

摘要

未加标签

在这里,我们使用线粒体 DNA(mtDNA)突变作为克隆扩增的标志物,研究人类肝硬化再生结节的克隆性和起源细胞。通过组织化学和免疫组织化学方法,通过缺乏完全由 mtDNA 编码的细胞色素 c 氧化酶(CCO)酶的表型特征来鉴定突变细胞。结节分为 CCO 缺乏或 CCO 阳性,在 10 例中的 526 个结节中,18%是均匀 CCO 缺乏,而只有 3%具有混合表型。从冷冻切片中,使用激光捕获微切割技术从单个 CCO 缺乏结节的多个部位分离肝细胞。通过聚合酶链反应对整个 mtDNA 基因组进行测序来鉴定突变。除了一个病例外,所有病例的结节均为单克隆性,在给定的结节中所有肝细胞中最多存在四种共同突变。此外,在毗邻 CCO 缺乏结节的肝祖细胞中鉴定出相同的突变证明结节可以起源于这些细胞。

结论

这些数据支持了肝祖细胞从人类肝硬化再生结节中单克隆衍生的新途径。

相似文献

1
The histogenesis of regenerative nodules in human liver cirrhosis.肝硬化患者肝脏再生结节的组织发生。
Hepatology. 2010 Mar;51(3):1017-26. doi: 10.1002/hep.23483.
2
Human cirrhosis: monoclonal regenerative nodules derived from hepatic progenitor cells abutting ductular reaction.人类肝硬化:源自肝祖细胞的单克隆再生结节紧邻小胆管反应。
Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):267-9. doi: 10.1016/j.gcb.2010.03.004. Epub 2010 Apr 28.
3
Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis.丙型肝炎病毒诱导的肝硬化中再生结节的克隆分析。
Gastroenterology. 1994 Dec;107(6):1805-11. doi: 10.1016/0016-5085(94)90824-9.
4
Locating the stem cell niche and tracing hepatocyte lineages in human liver.定位人类肝脏中的干细胞龛并追踪肝细胞谱系。
Hepatology. 2009 May;49(5):1655-63. doi: 10.1002/hep.22791.
5
Clonal architecture of human prostatic epithelium in benign and malignant conditions.人类前列腺上皮在良性和恶性条件下的克隆结构。
J Pathol. 2011 Oct;225(2):172-80. doi: 10.1002/path.2959. Epub 2011 Aug 24.
6
Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis.胚胎肝 fodrin 参与肝星状细胞激活和肝硬化再生结节形成。
J Cell Mol Med. 2012 Jan;16(1):118-28. doi: 10.1111/j.1582-4934.2011.01290.x.
7
Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.人肝硬化肝脏再生结节中微核形成和核异常的检测及其与肝细胞癌的关系。
Cancer Genet Cytogenet. 2004 Apr 1;150(1):16-21. doi: 10.1016/j.cancergencyto.2003.08.001.
8
Clonal analysis of micronodules in virus C-induced liver cirrhosis using laser capture microdissection (LCM) and HUMARA assay.利用激光捕获显微切割(LCM)和人类雄激素受体基因(HUMARA)分析对丙型肝炎病毒诱导的肝硬化中的微小结节进行克隆分析。
Lab Invest. 2000 Oct;80(10):1553-9. doi: 10.1038/labinvest.3780165.
9
Mutation of p53 gene in regenerative nodules in cirrhotic liver.肝硬化肝脏再生结节中p53基因的突变
J Hepatol. 2002 Aug;37(2):231-9. doi: 10.1016/s0168-8278(02)00144-7.
10
Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion.对显微切割的肝硬化结节进行的全蛋白质组分析揭示了与克隆性扩增相关的重要生物标志物。
Lab Invest. 2006 Sep;86(9):951-8. doi: 10.1038/labinvest.3700450. Epub 2006 Jul 17.

引用本文的文献

1
Evolutionary View of Liver Pathology.肝脏病理学的进化观点。
Evol Appl. 2024 Dec 22;17(12):e70059. doi: 10.1111/eva.70059. eCollection 2024 Dec.
2
Aberrant differentiation and proliferation of hepatocytes in chronic liver injury and liver tumors.慢性肝损伤和肝肿瘤中肝细胞的异常分化和增殖。
Pathol Int. 2024 Jul;74(7):361-378. doi: 10.1111/pin.13441. Epub 2024 Jun 5.
3
"Small Hepatocytes" in the Liver.肝脏中的“小肝细胞”。
Cells. 2023 Nov 27;12(23):2718. doi: 10.3390/cells12232718.
4
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis.血管内皮生长因子A信使核糖核酸脂质纳米颗粒在急慢性肝病中促进胆管上皮细胞向肝细胞转化,并逆转脂肪变性和肝纤维化。
Cell Stem Cell. 2023 Dec 7;30(12):1640-1657.e8. doi: 10.1016/j.stem.2023.10.008. Epub 2023 Nov 28.
5
Cell transplantation-based regenerative medicine in liver diseases.基于细胞移植的肝脏疾病再生医学。
Stem Cell Reports. 2023 Aug 8;18(8):1555-1572. doi: 10.1016/j.stemcr.2023.06.005.
6
Update on Hepatobiliary Plasticity.肝胆可塑性研究进展。
Semin Liver Dis. 2023 Feb;43(1):13-23. doi: 10.1055/s-0042-1760306. Epub 2023 Feb 10.
7
Mitotic protein kinase-driven crosstalk of machineries for mitosis and metastasis.有丝分裂蛋白激酶驱动的有丝分裂和转移机制的串扰。
Exp Mol Med. 2022 Apr;54(4):414-425. doi: 10.1038/s12276-022-00750-y. Epub 2022 Apr 4.
8
Cellular origins of regenerating liver and hepatocellular carcinoma.再生肝脏和肝细胞癌的细胞起源
JHEP Rep. 2021 Dec 13;4(4):100416. doi: 10.1016/j.jhepr.2021.100416. eCollection 2022 Apr.
9
Genetic Landscape of Multistep Hepatocarcinogenesis.多步骤肝癌发生的遗传图谱
Cancers (Basel). 2022 Jan 23;14(3):568. doi: 10.3390/cancers14030568.
10
Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development.控制肝硬化发展的炎症和非炎症机制
Cancers (Basel). 2021 Oct 9;13(20):5045. doi: 10.3390/cancers13205045.